In addition to EGFR, when we screened the RTKs commonly involved in ovarian tumor progression, we found that several RTKs with moderate expression levels can also be regulated by thyrostimulin-TSHR signaling in NIH:OVCAR 3 cells. The gene discussed is TSHR; the disease is ovarian neoplasm.